Journal of Rheumatic Diseases

Download original image
Fig. 2. Comparison of poor-outcome-free survival rates. There were no significant differences in the relapse-free and ESRD-free survival rates between the AAV patients with CH50 <62.1 U/mL and those with CH50 ≥62.1 U/mL. CH50: total haemolytic complement activity, ESRD: end-stage renal disease, AAV: antineutrophil cytoplasmic antibody- associated vasculitis.
J Rheum Dis 2021;28:85~93 https://doi.org/10.4078/jrd.2021.28.2.85
© J Rheum Dis